Publicacións nas que colabora con Enrique Bernal Morell (31)

2023

  1. Remdesivir plus dexamethasone is associated to improvement in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status

    Medicina Clinica, Vol. 161, Núm. 4, pp. 139-146

  2. Role of vaccination and anti-SARS-CoV-2 antibodies in the clinical outcome of hospitalized COVID-19 patients

    Medicina Clinica, Vol. 160, Núm. 11, pp. 476-483

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

    HIV Medicine, Vol. 23, Núm. 7, pp. 705-716

  3. Moderate to Intense Physical Activity Is Associated with Improved Clinical, CD4/CD8 Ratio, and Immune Activation Status in HIV-Infected Patients on ART

    Open Forum Infectious Diseases, Vol. 9, Núm. 3

2021

  1. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated with the Severity of Coronavirus Disease 2019

    Journal of Infectious Diseases, Vol. 224, Núm. 2, pp. 229-240

  2. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening

    Aging, Vol. 13, Núm. 14, pp. 18094-18105

2020

  1. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  2. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2019

  1. Association between erectile dysfunction and carotid subclinical atherosclerosis in HIV-infected patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 80, Núm. 4, pp. 429-435

  2. T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors

    Antiviral Research, Vol. 162, pp. 163-170

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  2. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

  3. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis

    Journal of Infection, Vol. 76, Núm. 3, pp. 249-257

2017

  1. Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study

    HIV Medicine, Vol. 18, Núm. 7, pp. 482-489

  2. Nomogram to predict a poor outcome in emergency patients with sepsis and at low risk of organ damage according to Sepsis-related Organ Failure Assessment (SOFA)

    Emergencias, Vol. 29, Núm. 2, pp. 81-86

  3. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

  4. The N-terminal pro brain natriuretic peptide is the best predictor of mortality during hospitalization in patients with low risk of sepsis-related organ failure

    Medicina Clinica, Vol. 149, Núm. 5, pp. 189-195

2016

  1. Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics

    Open Forum Infectious Diseases, Vol. 3, Núm. 2

  2. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596